WINDTREE THERAPEUTICS INC /DE/ Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Operating Income (Loss) for the quarter ending June 30, 2024 was -$11.5M, a 69.5% decline year-over-year.
  • Windtree Therapeutics Inc /De/ Operating Income (Loss) for the twelve months ending June 30, 2024 was -$25.5M, a 3.42% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2023 was -$20.6M, a 50.2% increase from 2022.
  • Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2022 was -$41.3M, a 46.5% increase from 2021.
  • Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2021 was -$77.3M, a 155% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$25.5M -$11.5M -$4.7M -69.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$20.8M -$4.41M -$214K -5.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.6M -$4.96M +$5.85M +54.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$26.5M -$4.69M -$40K -0.86% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$26.4M -$6.76M +$10.8M +61.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$37.2M -$4.19M +$4.14M +49.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$41.3M -$10.8M +$3.88M +26.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$45.2M -$4.65M +$3.5M +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$48.7M -$17.5M +$27.8M +61.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$76.5M -$8.33M +$746K +8.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$77.3M -$14.7M -$7.73M -111% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$69.5M -$8.15M +$558K +6.41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$70.1M -$45.4M -$37.4M -471% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$32.7M -$9.08M -$2.38M -35.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$30.3M -$6.96M -$2.41M -52.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$27.9M -$8.71M -$1.52M -21.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$26.4M -$7.95M -$1.45M -22.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$24.9M -$6.7M -$46K -0.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$24.9M -$4.55M +$297K +6.12% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-03
Q3 2019 -$25.2M -$7.19M -$3.72M -107% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$21.5M -$6.5M -$3.46M -114% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$18M -$6.66M -$1.82M -37.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$16.2M -$4.85M -$1.35M -38.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 -$14.8M -$3.47M +$1.33M +27.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-03
Q2 2018 -$16.2M -$3.04M +$3.1M +50.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-03
Q1 2018 -$19.3M -$4.84M +$3.28M +40.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-04-03
Q4 2017 -$22.5M -$3.5M +$2.87M +45.1% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$25.4M -$4.79M +$2.94M +38% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-04-23
Q2 2017 -$28.4M -$6.14M +$3.85M +38.6% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-04-23
Q1 2017 -$32.2M -$8.12M +$5.83M +41.8% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-04-23
Q4 2016 -$38M -$6.37M +$3.41M +34.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$41.4M -$7.73M +$710K +8.41% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-17
Q2 2016 -$42.2M -$9.99M +$444K +4.25% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-17
Q1 2016 -$42.6M -$13.9M -$2.77M -24.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-17
Q4 2015 -$39.8M -$9.78M +$1.45M +12.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$41.3M -$8.44M +$1.88M +18.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$43.2M -$10.4M +$505K +4.62% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$43.7M -$11.2M -$410K -3.81% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
Q4 2014 -$43.3M -$11.2M -$961K -9.36% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 -$42.3M -$10.3M +$486K +4.5% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-03-29
Q2 2014 -$42.8M -$10.9M -$132K -1.22% Apr 1, 2014 Jun 30, 2014 10-K/A 2016-03-29
Q1 2014 -$42.7M -$10.8M +$1.86M +14.7% Jan 1, 2014 Mar 31, 2014 10-K/A 2016-03-29
Q4 2013 -$44.5M -$10.3M +$2.16M +17.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$46.7M -$10.8M -$815K -8.15% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$45.9M -$10.8M -$1.99M -22.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$43.9M -$12.6M -$6.04M -91.8% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$37.8M -$12.4M -$6.52M -110% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$31.3M -$10M -$3.83M -62% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$27.5M -$8.82M -$2.44M -38.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$25M -$6.58M -$521K -8.6% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$24.5M -$5.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$6.17M +$33K +0.53% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$6.38M -$152K -2.44% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$6.06M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$6.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$6.23M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.